85 related articles for article (PubMed ID: 29371707)
1. Illuminating MSK1's role in tumour dormancy.
Grzelak CA; Ghajar CM
Nat Cell Biol; 2018 Feb; 20(2):124-126. PubMed ID: 29371707
[No Abstract] [Full Text] [Related]
2. MSK1 regulates luminal cell differentiation and metastatic dormancy in ER
Gawrzak S; Rinaldi L; Gregorio S; Arenas EJ; Salvador F; Urosevic J; Figueras-Puig C; Rojo F; Del Barco Barrantes I; Cejalvo JM; Palafox M; Guiu M; Berenguer-Llergo A; Symeonidi A; Bellmunt A; Kalafatovic D; Arnal-Estapé A; Fernández E; Müllauer B; Groeneveld R; Slobodnyuk K; Stephan-Otto Attolini C; Saura C; Arribas J; Cortes J; Rovira A; Muñoz M; Lluch A; Serra V; Albanell J; Prat A; Nebreda AR; Benitah SA; Gomis RR
Nat Cell Biol; 2018 Feb; 20(2):211-221. PubMed ID: 29358704
[TBL] [Abstract][Full Text] [Related]
3. RSK4 knockdown promotes proliferation, migration and metastasis of human breast adenocarcinoma cells.
Zhu J; Li QY; Liu JL; Wei W; Yang HW; Tang W
Oncol Rep; 2015 Dec; 34(6):3156-62. PubMed ID: 26397146
[TBL] [Abstract][Full Text] [Related]
4. The impact of bone morphogenetic protein 4 (BMP4) on breast cancer metastasis in a mouse xenograft model.
Ampuja M; Alarmo EL; Owens P; Havunen R; Gorska AE; Moses HL; Kallioniemi A
Cancer Lett; 2016 Jun; 375(2):238-244. PubMed ID: 26970275
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs.
Capulli M; Angelucci A; Driouch K; Garcia T; Clement-Lacroix P; Martella F; Ventura L; Bologna M; Flamini S; Moreschini O; Lidereau R; Ricevuto E; Muraca M; Teti A; Rucci N
J Bone Miner Res; 2012 Nov; 27(11):2387-98. PubMed ID: 22714395
[TBL] [Abstract][Full Text] [Related]
6. [Effects of breast cancer cells stably overexpressing RSK4 on growth of transplanted human breast cancer in severe combined immunodeficiency mice].
Yang HW; Liu JL; Liao DZ; Sun Y; Chen ZS; Zhang XL
Zhonghua Yi Xue Za Zhi; 2012 Jul; 92(26):1845-8. PubMed ID: 22944237
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of TRAF4 targeting RSK4 inhibits proliferation, invasion and metastasis in breast cancer xenografts.
Zhu L; Zhang S; Huan X; Mei Y; Yang H
Biochem Biophys Res Commun; 2018 Jun; 500(3):810-816. PubMed ID: 29684350
[TBL] [Abstract][Full Text] [Related]
8. Increased regucalcin gene expression extends survival in breast cancer patients: Overexpression of regucalcin suppresses the proliferation and metastatic bone activity in MDA-MB-231 human breast cancer cells in vitro.
Yamaguchi M; Osuka S; Weitzmann MN; Shoji M; Murata T
Int J Oncol; 2016 Aug; 49(2):812-22. PubMed ID: 27221776
[TBL] [Abstract][Full Text] [Related]
9. A "bone" fide predictor of metastasis? Predicting breast cancer metastasis to bone.
Kominsky SL; Davidson NE
J Clin Oncol; 2006 May; 24(15):2227-9. PubMed ID: 16636338
[No Abstract] [Full Text] [Related]
10. Tumour dormancy in inflammatory microenvironment: A promising therapeutic strategy for cancer-related bone metastasis.
Hu W; Zhang L; Dong Y; Tian Z; Chen Y; Dong S
Cell Mol Life Sci; 2020 Dec; 77(24):5149-5169. PubMed ID: 32556373
[TBL] [Abstract][Full Text] [Related]
11. Functions and Epigenetic Regulation of Wwox in Bone Metastasis from Breast Carcinoma: Comparison with Primary Tumors.
Maroni P; Matteucci E; Bendinelli P; Desiderio MA
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28045433
[TBL] [Abstract][Full Text] [Related]
12. Osteoblast-like cells in human cancers: new cell type and reliable markers for bone metastasis.
Scimeca M; Bonfiglio R; Montanaro M; Bonanno E
Future Oncol; 2018 Jan; 14(1):9-11. PubMed ID: 29219614
[No Abstract] [Full Text] [Related]
13. The Clinical Implications of RSK1-3 in Human Breast Cancer.
Zhao H; Martin TA; Davies EL; Ruge F; Yu H; Zhang Y; Teng XU; Jiang WG
Anticancer Res; 2016 Mar; 36(3):1267-74. PubMed ID: 26977024
[TBL] [Abstract][Full Text] [Related]
14. miR-429 inhibits migration and invasion of breast cancer cells in vitro.
Ye ZB; Ma G; Zhao YH; Xiao Y; Zhan Y; Jing C; Gao K; Liu ZH; Yu SJ
Int J Oncol; 2015 Feb; 46(2):531-8. PubMed ID: 25405387
[TBL] [Abstract][Full Text] [Related]
15. Tumour but not stromal expression of β3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer.
Carter RZ; Micocci KC; Natoli A; Redvers RP; Paquet-Fifield S; Martin AC; Denoyer D; Ling X; Kim SH; Tomasin R; Selistre-de-Araújo H; Anderson RL; Pouliot N
J Pathol; 2015 Apr; 235(5):760-72. PubMed ID: 25430721
[TBL] [Abstract][Full Text] [Related]
16. Melatonin Represses Metastasis in Her2-Postive Human Breast Cancer Cells by Suppressing RSK2 Expression.
Mao L; Summers W; Xiang S; Yuan L; Dauchy RT; Reynolds A; Wren-Dail MA; Pointer D; Frasch T; Blask DE; Hill SM
Mol Cancer Res; 2016 Nov; 14(11):1159-1169. PubMed ID: 27535706
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of RSK2 influences the biological activities of human osteosarcoma cells through inactivating AKT/mTOR signaling pathways.
Qiu Q; Jiang J; Lin L; Cheng S; Xin D; Jiang W; Shen J; Hu Z
Int J Oncol; 2016 Jun; 48(6):2508-20. PubMed ID: 27082640
[TBL] [Abstract][Full Text] [Related]
18. Systemic osteoprotegerin gene therapy restores tumor-induced bone loss in a therapeutic model of breast cancer bone metastasis.
Chanda D; Isayeva T; Kumar S; Siegal GP; Szafran AA; Zinn KR; Reddy VV; Ponnazhagan S
Mol Ther; 2008 May; 16(5):871-8. PubMed ID: 18388919
[TBL] [Abstract][Full Text] [Related]
19. ABL kinases promote breast cancer osteolytic metastasis by modulating tumor-bone interactions through TAZ and STAT5 signaling.
Wang J; Rouse C; Jasper JS; Pendergast AM
Sci Signal; 2016 Feb; 9(413):ra12. PubMed ID: 26838548
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
